← Back to Patent Explorer
US5235033A Expired / Lapsed US ⏱️ 0.0 years remaining

Alpha-morpholino ribonucleoside derivatives and polymers thereof

Assignee: Sarepta Therapeutics Inc
•
Filing: 1989-12-20
•
Granted: 1993-08-10
•
Expires: 2009-12-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Alpha-morpholino subunits and polymer compositions composed of alpha-morpholino subunits are disclosed. These subunits can be linked together by uncharged linkages, one to three atoms in length, joining the morpholino nitrogen of one subunit to the 5' exocyclic carbon of an adjacent subunit. Each subunit contains a purine or pyrimidine base-pairing moiety effective to bind by hydrogen bonding to a specific base or base-pair in a target polynucleotide. The polymers of the present invention can be used in place of standard RNA or DNA oligomers for a number of standard laboratory procedures, for example, as probes in solid-phase systems and nucleic acid hybridization analyses. Further, the polymers of the present invention have potential use as therapeutic agents in anti-sense-type technologies.

Inventors

  • 👤 James E. Summerton
  • 👤 Dwight D. Weller
  • 👤 Eugene P. Stirchak

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 20:35
CPC Classifications
C; C07; C07H; C07H21/00; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/54; A61K47/545; A61K47/56; A61K47/59; C07K; C07K14/00; C07K14/001; C07K14/003; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816; C12Q1/682; B; B01; B01J; B01J2219/00; B01J2219/00274; B01J2219/00718; B01J2219/0072

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 67 words
A polymer composition comprised of α-morpholino subunit structures of the form: ##STR2## where (i) the structures are linked together by uncharged linkages, one to three atoms long, joining the morpholino nitrogen of one subunit to the 5', exocyclic carbon of an adjacent subunit, and (ii) P i is a purine or pyrimidine base-pairing moiety effective to bind by base-specific hydrogen bonding to a base in a polynucleotide.
Claim 2
Dependent Claim 67 words
A polymer composition comprised of α-morpholino subunit structures of the form: ##STR2## where (i) the structures are linked together by uncharged linkages, one to three atoms long, joining the morpholino nitrogen of one subunit to the 5', exocyclic carbon of an adjacent subunit, and (ii) P i is a purine or pyrimidine base-pairing moiety effective to bind by base-specific hydrogen bonding to a base in a polynucleotide.
Claim 3
Dependent Claim 28 words
The composition of claim 1, wherein P i is selected from the group consisting of: ##STR3## where X is H, CH 3 , F, Cl, Br, or I.
Claim 4
Dependent Claim 19 words
The composition of claim 1, wherein the linked structures have a form selected from the group consisting of: ##STR4##
Claim 5
Dependent Claim 36 words
The composition of claim 1, wherein the linkage is of the form: ##STR5## where P j is a purine or pyrimidine base-pairing moiety effective to bind by base-specific hydrogen bonding to a base in a polynucleotide.
Claim 6
Dependent Claim 46 words
The composition of claim 1, wherein the linkage is of the form: ##STR6## where R is H, CH 3 , or other alkyl; and, P j is a purine or pyrimidine base-pairing moiety effective to bind by base-specific hydrogen bonding to a base in a polynucleotide.
Claim 7
Dependent Claim 49 words
The composition of claim 1, wherein the linkage is of the form: ##STR7## where X is alkyl, alkoxy, thioalkoxy, or an unsubstituted, monosubstituted, or disubstituted nitrogen; and, P j is a purine or pyrimidine base-pairing moiety effective to bind by base-specific hydrogen bonding to a base in a polynucleotide.
Claim 8
Dependent Claim 56 words
The composition of claim 1, wherein the linkage is of the form: ##STR8## where X is alkyl, alkoxy, thioalkoxy, or an unsubstituted, monosubstituted, or disubstituted nitrogen; R is H or CH 3 ; and P j is a purine or pyrimidine base-pairing moiety effective to bind by base-specific hydrogen bonding to a base in a polynucleotide.
Claim 9
Dependent Claim 49 words
The composition of claim 1, wherein the linkage is of the form: ##STR9## where X is alkyl, alkoxy, thioalkoxy, or an unsubstituted, monosubstituted, or disubstituted nitrogen; and, P j is a purine or pyrimidine base-pairing moiety effective to bind by base-specific hydrogen bonding to a base in a polynucleotide.
Claim 10
Dependent Claim 56 words
The composition of claim 1, wherein the linkage is of the form: ##STR10## where X is alkyl, alkoxy, thioalkoxy, or an unsubstituted, monosubstituted, or disubstituted nitrogen; R is H or CH 3 ; and P j is a purine or pyrimidine base-pairing moiety effective to bind by base-specific hydrogen bonding to a base in a polynucleotide.
Claim 11
Dependent Claim 47 words
The composition of claim 1, wherein the linkage is of the form ##STR11## where R is H or CH 3 , or other alkyl; and P j is a purine or pyrimidine base-pairing moiety effective to bind by base-specific hydrogen bonding to a base in a polynucleotide.
Claim 12
Dependent Claim 28 words
The composition of claim 1, which further includes a moiety at one or both termini which is effective to enhance the solubility of the polymer in aqueous medium.
Claim 13
Dependent Claim 12 words
The composition of claim 11, wherein the terminal moiety is polyethylene glycol.
Claim 14
Dependent Claim 12 words
The composition of claim 1, composed of at least 3 morpholino subunits.
Claim 15
Dependent Claim 16 words
The composition of claim 1, wherein at least one of the P i is a 2,6-diaminopurine.
Claim 16
Dependent Claim 16 words
The composition of claim 1, wherein at least one of the P i is a 5-halouracil.
Claim 17
Dependent Claim 17 words
The composition of claim 1, wherein at least 70% of the P i are 2-amine containing purines.

References Cited (Backward Citations)

US4558047A Cited
WO1986005519A1 Cited
WO1986005518A1 Cited
US5034506A Cited
JPH09118898A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-08-09 1997-02-08 1997-08-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-08-09 2001-02-08 2001-08-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-08-09 2005-02-08 2005-08-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag